SEC Form 4 · accession 0001674236-26-000013
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen P. Carey
Officer — SVP & CFO
Period of report
Jun 5, 2026
Accepted (ET)
Jun 9, 2026 · 6:33 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2026 | M | 3,312 | $49.51 | A | 183,705 | D | |
| Common Stock | Jun 5, 2026 | S | 3,312 | $80.00 | D | 180,393 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $49.51 | Jun 5, 2026 | M | 3,312 | D | — | Mar 30, 2027 | Common Stock | 3,312 | 6,626 | D |
Explanation of responses
- F1The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
- F225% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.